tiprankstipranks
Sinopharm Group Co Ltd Class H (HK:1099)
HKEX:1099

Sinopharm Group Co (1099) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

1099 Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Sinopharm
Group Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1099 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:1099 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

1099 Financial Forecast

1099 Earnings Forecast

Next quarter’s earnings estimate for 1099 is HK$1.54 with a range of HK$1.54 to HK$1.54. The previous quarter’s EPS was HK$0.49. 1099 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 41.32% of the time in the same period. In the last calendar year 1099 has Underperformed its overall industry.
Next quarter’s earnings estimate for 1099 is HK$1.54 with a range of HK$1.54 to HK$1.54. The previous quarter’s EPS was HK$0.49. 1099 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 41.32% of the time in the same period. In the last calendar year 1099 has Underperformed its overall industry.

1099 Sales Forecast

Next quarter’s sales forecast for 1099 is HK$335.02B with a range of HK$335.02B to HK$335.02B. The previous quarter’s sales results were ―. 1099 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 55.77% of the time in the same period. In the last calendar year 1099 has Outperformed its overall industry.
Next quarter’s sales forecast for 1099 is HK$335.02B with a range of HK$335.02B to HK$335.02B. The previous quarter’s sales results were ―. 1099 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 55.77% of the time in the same period. In the last calendar year 1099 has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
HSBC
HK$23.19HK$23
Hold
17.35%
Upside
Reiterated
03/28/24
Sinopharm Group Co Ltd. (1099:HK) (SHTDF) PT Lowered to HK$23 at HSBCHSBC analyst Linda Shu lowered the price target on Sinopharm Group Co Ltd. (1099:HK) (OTC: SHTDF) to HK$23.00 (from HK$23.19) while maintaining a Hold rating.
DBS
HK$29.3
Buy
49.49%
Upside
Reiterated
03/26/24
Buy Rating for Sinopharm Group Co. Amidst Market Consolidation and Efficiency Gains
CLSA
HK$27.1HK$27
Buy
37.76%
Upside
Reiterated
03/26/24
Sinopharm Group Co Ltd. (1099:HK) (SHTDF) PT Lowered to HK$27 at CLSACLSA analyst Zhijie Zhao lowered the price target on Sinopharm Group Co Ltd. (1099:HK) (OTC: SHTDF) to HK$27.00 (from HK$27.10) while maintaining a Buy (1) rating.
Morgan Stanley
HK$29
Buy
47.96%
Upside
Reiterated
03/21/24
Sinopharm Group Co.: Strong Buy Rating on Robust Growth and Recovery Prospects
Nomura
HK$33.31HK$32.39
Buy
65.26%
Upside
Reiterated
03/11/24
Sinopharm Group Co Ltd. (1099:HK) (SHTDF) PT Lowered to HK$32.39 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang lowered the price target on Sinopharm Group Co Ltd. (1099:HK) (OTC: SHTDF) to HK$32.39 (from HK$33.31) while maintaining a Buy rating.
Citi
HK$26
Buy
32.65%
Upside
Reiterated
11/03/23
Citi Reiterates Buy Rating on Sinopharm Group Co Ltd. (1099:HK) (SHTDF)Citi analyst Cui Cui reiterated a Buy rating and HK$26.00 price target on Sinopharm Group Co Ltd. (1099:HK) (OTC: SHTDF).

Best Analysts Covering Sinopharm Group Co

Which Analyst Should I Follow If I Want to Buy HK:1099 and Sell After:
1 Month
Laurence TamMorgan Stanley
Success Rate
0/2 ratings generated profit
0%
Average Return
-1.85%
reiterated a buy rating 4 months ago
Copying Laurence Tam's trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -1.85% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Laurence TamMorgan Stanley
Success Rate
2/2 ratings generated profit
100%
Average Return
+6.70%
reiterated a buy rating 4 months ago
Copying Laurence Tam's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +6.70% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Laurence TamMorgan Stanley
Success Rate
1/2 ratings generated profit
50%
Average Return
-1.45%
reiterated a buy rating 4 months ago
Copying Laurence Tam's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -1.45% per trade.
2 Years
Laurence TamMorgan Stanley
Success Rate
1/2 ratings generated profit
50%
Average Return
-1.45%
reiterated a buy rating 4 months ago
Copying Laurence Tam's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -1.45% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1099 Analyst Recommendation Trends

Rating
May 23
Jul 23
Nov 23
Dec 23
Mar 24
Strong Buy
1
2
3
3
6
Buy
0
0
0
0
0
Hold
2
1
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
7
In the current month, 1099 has received 6 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 1099 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

1099 Stock Forecast FAQ

What is HK:1099’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:1099’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:1099, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Sinopharm Group Co Ltd Class H a Buy, Sell or Hold?
      Currently, no data Available
      What is Sinopharm Group Co Ltd Class H’s share price target?
      Currently, no data Available
      What do analysts say about Sinopharm Group Co Ltd Class H?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Sinopharm Group Co Ltd Class H?
      To buy shares of HK:1099, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis